Concerns about Elon Musk’s drug use have been raised by some Tesla and SpaceX board members, and there have been reports that the board has taken some action to address these concerns.
Specific concerns
- Impaired judgment and decision-making: Some board members have expressed concern that Musk’s drug use could impair his judgment and decision-making, potentially leading to risky or irresponsible actions that could harm the companies.
- Damage to reputation: Musk’s public statements about his drug use have raised concerns that it could damage the reputations of Tesla and SpaceX, making them appear irresponsible and unprofessional.
- Legal and regulatory risks: Musk’s drug use could expose Tesla and SpaceX to legal and regulatory risks, such as allegations of insider trading or securities fraud.
Board actions
- Discussions with Musk: The board has reportedly discussed Musk’s drug use with him privately, expressing their concerns and urging him to be more discreet about his behavior.
- Investigations: There have been reports that the board has conducted or commissioned investigations into Musk’s drug use to assess the extent of the issue and its potential impact on the companies.
- Establishment of policies: The board has reportedly established or reviewed policies and procedures regarding drug use among company executives, including Musk.
- Consideration of disciplinary action: The board has reportedly considered taking disciplinary action against Musk, such as reprimands, fines, or even termination, if his drug use continues to be a problem.
It is important to note that the specific actions taken by the board are not publicly known, and there is no consensus among sources about the extent of the board’s involvement in addressing Musk’s drug use. However, the reports suggest that the board is taking the issue seriously and is taking steps to protect the companies’ interests.